Udvidet returret til d. 31. januar 2025

Bøger i Cancer Treatment and Research serien

Filter
Filter
Sorter efterSorter Serie rækkefølge
  •  
    2.193,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single per sonal subscription.

  •  
    1.843,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  •  
    1.100,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  • - Including Hodgkin's disease
     
    1.113,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  •  
    1.695,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  •  
    1.692,95 kr.

    Kidney cancer is a heterogenous disease. This book will be useful to the specialist (oncologist and urologist), primary care physicians, patients and family members dealing with kidney cancer.

  • - Directions for the New Millennium
     
    1.695,95 kr.

    Attempts to harness the inherent complexity of MDS by devising `classifications' which group the various syndromes as one disease is as misguided as saying that a pneumonia is not infectious because it did not respond to antibiotics.

  •  
    1.125,95 kr.

    As a result, this multi-authored volume, devoted to advances which have occurred over the last seven years, provides the reader with an important new understanding of leukemia, but perhaps even more important, predicts analogous, new developments in the other malignant diagnoses.

  •  
    3.262,95 kr.

    Gastric cancer has been one of the great malignant scourges affecting man kind for as long as medical records have been kept. Some changes have resulted from better understanding of the disease, early detec tion, and better management techniques with applied clinical research, but the reasons for other changes are poorly understood.

  • - Advances in Cellular and Molecular Biology of Breast Cancer
     
    2.196,95 kr.

    In Breast Cancer: Cellular and Molecular Biology [Kluwer Academic Pub lishers, 1988], we tried to present an introduction to the emerging basic studies on steroid receptors, oncogenes, and growth factors in the regulation of normal and malignant mammary epithelium.

  •  
    5.400,95 kr.

    In recent years, there have been major advances in the treatment of patients with gynecologic malignancies. The advances made in the treatment of gynecologic malignancies are due, in part, to the clinical studies performed by many of the contributors to this volume.

  •  
    2.180,95 kr.

    Section One, `Diagnostic advances: the use of molecular medicine in the diagnosis and prognosis of GU malignancies', details how epidemiologic studies and new molecular techniques are impacting our ability to diagnose and treat GU tumors.

  •  
    3.253,95 kr.

    Infection is a major cause of morbidity and mortality in patients with neoplastic disease because of compromised host defenses. The goal of this volume in the Cancer Treatment and Research series is to emphasize that while the management of infection in cancer patients is common, it is constantly changing.

  •  
    1.701,95 kr.

    One of the most exciting areas of cancer research now is the development of agents which can target signal transduction pathways that are activated inappropriately in malignant cells.

  •  
    1.699,95 kr.

    This book brings together up-to-date summaries by leading cancer researchers on the major principles of cancer cell biology: survival, apoptosis, adhesion, and cell cycle deregulation.

  •  
    609,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  •  
    1.109,95 kr.

  •  
    562,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  • - with a special section on Rare Primitive Neuroectodermal Tumors
     
    562,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  •  
    591,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  • - Including Hodgkin's Disease
     
    609,95 kr.

    It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

  •  
    1.724,95 kr.

    While advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neo plastic disease.

  •  
    1.703,95 kr.

    - Volume is divided into four sections, allowing easy navagation for researchers and practicing physicians- Text includes clinical trials- Written by leaders in the field

  •  
    2.173,95 kr.

    Policy and outcome studies represent a new area of research in oncology. Understanding the factors that affect quality of life, costs of care, patterns of care, and outcomes in oncology is important to providing comprehensive care. In sum, Cancer Policy highlights some of the important areas of health services research in oncology.

  • - Fertility Preservation for Cancer Survivors
     
    1.650,95 kr.

    In the past, pregnancy after cancer was largely unheard of. Oncofertility has emerged as an interdisciplinary field bridging biomedical and social sciences, and examining issues regarding an individual's fertility options, choice and goals in light of cancer diagnosis, treatment and survivorship.

  •  
    4.098,95 kr.

    The field of medicine relating to haematologic malignancies is one in which advances in therapy have been closely linked to a better understanding of molecular medicine. This text aims to provide practitioners with an understanding of the constantly evolving concepts in this area.

  •  
    3.380,95 kr.

    The purpose of Diagnostic and Therapeutic Advances in Pediatric Oncology for the Cancer Treatment and Research Series is to provide an up-to-date summary of how recent advances in cancer research are being applied to the care of children with solid tumors.

  •  
    1.706,95 kr.

    As in CANCER CHEMOTHERAPY 1, this volume brings to the reader highlights in three different areas of cancer therapeutics: new concepts and models;

  •  
    1.228,95 kr.

    Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types.

Gør som tusindvis af andre bogelskere

Tilmeld dig nyhedsbrevet og få gode tilbud og inspiration til din næste læsning.